Cidara Therapeutics Reports Positive Topline Results in Phase 2 STRIVE B Trial of Antifungal Rezafungin

    NEXT STORY
    Unum Therapeutics Announces New Appointments to its Board of Directors
    PREV STORY
    GENFIT: FDA and EMA Grant GENFIT’s Elafibranor Orphan Drug Designation for Primary Biliary Cholangitis (PBC)
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    MediciNova Announces SARS-CoV-2 Vaccine Joint Development with BioComo and Mie University Japan

    author_avatar
    NASDAQ Market News

    Ascendis Pharma Announces Filing of Investigational New Drug (IND) Application for Initiation of a Global Phase 2 Trial for TransCon™ CNP in Children with Achondroplasia

    author_avatar
    NASDAQ Market News

    Generex Biotechnology Announces Agenda for Shareholder Conference Call on Wednesday August 26th, 2020 at 9:30 AM

    author_avatar
    NASDAQ Market News